Atwood & Palmer Inc Biogen Inc. Transaction History

Atwood & Palmer Inc

  • $1.45 Billion
  • Q3 2024

A detailed history of Atwood & Palmer Inc transactions in Biogen Inc. stock. As of the latest transaction made, Atwood & Palmer Inc holds 5 shares of BIIB stock, worth $750. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5
Previous 8 37.5%
Holding current value
$750
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024
SELL
$189.07 - $236.8 $567 - $710
-3 Reduced 37.5%
5 $0
Q1 2024

Apr 10, 2024
SELL
$212.02 - $267.71 $8.82 Million - $11.1 Million
-41,588 Reduced 99.98%
8 $1,000
Q4 2023

Jan 12, 2024
SELL
$222.59 - $267.94 $8,903 - $10,717
-40 Reduced 0.1%
41,596 $10.8 Million
Q3 2023

Oct 20, 2023
SELL
$253.3 - $285.89 $16,717 - $18,868
-66 Reduced 0.16%
41,636 $10.7 Million
Q2 2023

Jul 18, 2023
BUY
$275.25 - $318.06 $279,103 - $322,512
1,014 Added 2.49%
41,702 $11.9 Million
Q1 2023

Apr 21, 2023
BUY
$256.56 - $292.34 $13,854 - $15,786
54 Added 0.13%
40,688 $11.3 Million
Q4 2022

Jan 31, 2023
BUY
$252.44 - $306.72 $139,346 - $169,309
552 Added 1.38%
40,634 $11.3 Million
Q3 2022

Oct 12, 2022
BUY
$194.69 - $268.46 $93,061 - $128,323
478 Added 1.21%
40,082 $10.7 Million
Q2 2022

Jul 21, 2022
SELL
$187.54 - $223.02 $326,319 - $388,054
-1,740 Reduced 4.21%
39,604 $8.08 Million
Q1 2022

Apr 29, 2022
BUY
$193.77 - $244.14 $22,671 - $28,564
117 Added 0.28%
41,344 $8.71 Million
Q4 2021

Jan 24, 2022
BUY
$223.92 - $287.77 $236,459 - $303,885
1,056 Added 2.63%
41,227 $9.89 Million
Q3 2021

Oct 19, 2021
BUY
$282.99 - $369.05 $99,895 - $130,274
353 Added 0.89%
40,171 $11.4 Million
Q2 2021

Jul 26, 2021
BUY
$259.0 - $414.71 $121,730 - $194,913
470 Added 1.19%
39,818 $13.8 Million
Q1 2021

Apr 26, 2021
BUY
$242.95 - $284.63 $131,921 - $154,554
543 Added 1.4%
39,348 $11 Million
Q4 2020

Feb 04, 2021
BUY
$236.26 - $355.63 $276,424 - $416,087
1,170 Added 3.11%
38,805 $9.5 Million
Q3 2020

Oct 28, 2020
BUY
$264.77 - $305.71 $45,010 - $51,970
170 Added 0.45%
37,635 $10.7 Million
Q2 2020

Jul 24, 2020
BUY
$258.66 - $342.55 $9.56 Million - $12.7 Million
36,965 Added 7393.0%
37,465 $10 Million
Q3 2019

Oct 21, 2019
SELL
$217.44 - $243.88 $43,488 - $48,776
-200 Reduced 28.57%
500 $116,000
Q2 2017

Aug 08, 2017
BUY
N/A
700
700 $190,000

Others Institutions Holding BIIB

# of Institutions
1,037
Shares Held
126M
Call Options Held
1.13M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.6B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Atwood & Palmer Inc Portfolio

Follow Atwood & Palmer Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atwood & Palmer Inc, based on Form 13F filings with the SEC.

News

Stay updated on Atwood & Palmer Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email